CA2042534A1 - Traitement et methode connexe - Google Patents

Traitement et methode connexe

Info

Publication number
CA2042534A1
CA2042534A1 CA2042534A CA2042534A CA2042534A1 CA 2042534 A1 CA2042534 A1 CA 2042534A1 CA 2042534 A CA2042534 A CA 2042534A CA 2042534 A CA2042534 A CA 2042534A CA 2042534 A1 CA2042534 A1 CA 2042534A1
Authority
CA
Canada
Prior art keywords
treatment
treating
viral infections
equine viral
caffeine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2042534A
Other languages
English (en)
Other versions
CA2042534C (fr
Inventor
Oswald Edmonds Hooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NZ23132289A external-priority patent/NZ231322A/xx
Priority claimed from NZ23397390A external-priority patent/NZ233973A/xx
Priority to AU65875/90A priority Critical patent/AU642173B2/en
Priority to CA002042534A priority patent/CA2042534C/fr
Priority to GB9110413A priority patent/GB2255718B/en
Application filed by Individual filed Critical Individual
Priority to JP3205011A priority patent/JP2731051B2/ja
Priority to US07/895,236 priority patent/US5275828A/en
Publication of CA2042534A1 publication Critical patent/CA2042534A1/fr
Publication of CA2042534C publication Critical patent/CA2042534C/fr
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002042534A 1989-11-08 1991-05-14 Traitement et methode connexe Expired - Fee Related CA2042534C (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU65875/90A AU642173B2 (en) 1989-11-08 1990-11-07 Improvements in or relating to a treatment and or a method of treating
CA002042534A CA2042534C (fr) 1989-11-08 1991-05-14 Traitement et methode connexe
GB9110413A GB2255718B (en) 1989-11-08 1991-05-14 Pharmaceutical composition for treating bacterial and / or viral infection
JP3205011A JP2731051B2 (ja) 1989-11-08 1991-05-15 馬ウィルス感染に関する医薬組成物及びその治療方法
US07/895,236 US5275828A (en) 1989-11-08 1992-06-08 Treatment and/or a method of treating equine viral and bacterial infections

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NZ23132289A NZ231322A (en) 1989-11-08 1989-11-08 Treatment of viral and/or bacterial infections
NZ23397390A NZ233973A (en) 1989-11-08 1990-06-07 Treatment of viral and/or bacterial infections
CA002042534A CA2042534C (fr) 1989-11-08 1991-05-14 Traitement et methode connexe
JP3205011A JP2731051B2 (ja) 1989-11-08 1991-05-15 馬ウィルス感染に関する医薬組成物及びその治療方法

Publications (2)

Publication Number Publication Date
CA2042534A1 true CA2042534A1 (fr) 1992-11-15
CA2042534C CA2042534C (fr) 1996-11-12

Family

ID=27426852

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002042534A Expired - Fee Related CA2042534C (fr) 1989-11-08 1991-05-14 Traitement et methode connexe

Country Status (4)

Country Link
JP (1) JP2731051B2 (fr)
AU (1) AU642173B2 (fr)
CA (1) CA2042534C (fr)
GB (1) GB2255718B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996032952A1 (fr) * 1995-04-21 1996-10-24 Oswald Edmonds Hooper Composition a base de cafeine utilisee en tant que medicament et son utilisation
AU751364B2 (en) * 1997-09-02 2002-08-15 Oswald Edmonds Hooper Medicament including potassium iodide and ammonium chloride
DK2222314T3 (da) * 2007-11-23 2013-04-15 Pharmalundensis Ab Anvendelser og midler til opnåelse af bronchorelaxation
US8840934B2 (en) * 2009-01-02 2014-09-23 Rainbow Pharmaceutical Sa Uses of ammonium chloride

Also Published As

Publication number Publication date
JP2731051B2 (ja) 1998-03-25
AU6587590A (en) 1991-05-16
GB9110413D0 (en) 1991-07-03
JPH05112457A (ja) 1993-05-07
AU642173B2 (en) 1993-10-14
GB2255718B (en) 1995-05-10
CA2042534C (fr) 1996-11-12
GB2255718A (en) 1992-11-18

Similar Documents

Publication Publication Date Title
CA2213339A1 (fr) Procede de traitement de la depletion de l'adenosine
GB8821049D0 (en) Method & composition for treatment & prevention of viral infections
AR240251A1 (es) Metodo para preparar una composicion para tratamiento de infecciones virales y un metodo para sintetizar 3' azido 2', 3' dideoxiuridina destinada a la preparacion de dicha composicion.
LTIP919A (en) Drugs and process for preparing thereof
OA08581A (en) Treatment of diseases caused by retroviruses.
PH23867A (en) Method of treating parkinson's disease using indolone derivatives
CA2024188A1 (fr) Methode de traitement de l'ejaculation prematuree a l'aide de la sertraline
AU1331588A (en) Method for treatment of alcohol abuse
HU901585D0 (en) Method for treatment of viral infections using functional derivatives of icam-1
LTIP863A (en) Aminobenzodiazepines, process for preparing thereof and application for the treatment and prevention of viral diseases
PT86362A (en) Process for the preparation of anxiolytic compositions containing n-(1-azabicyclo ]2,2.2."-oct-3-yl) benzamides and thiobenzamides
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
GB2246345B (en) Process for the recovery of titanium values
AU5317390A (en) Concentrated aqueous solution of glutaraldehyde and 1,2-benzisothiazolin-3-one
EP0608212A4 (fr) Procede de traitement des infections virales.
AU587706B2 (en) Process for the recovery of ammonia and fluoride values from ammonium fluoride solutions
CA2042534A1 (fr) Traitement et methode connexe
EP0264744A3 (en) Process for the preparation of 4,4'-diaminodiphenylmethane and its derivatives.
PT87004A (pt) Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
EP0273310A3 (fr) 5-Aryl-3H-1,2,4-triazol-3-ones et leur emploi comme anticonvulsifs
CA2138793A1 (fr) Utilisation du venin de l'hymenoptere pour la fabrication d'un medicament servant au traitement d'infections causees par des virus a adn
YU222189A (en) 2-azabicyclo (2.2.1) hept-5-en-2-ocetic acid, it's derivatives and familiar compounds, process for obtaining those compounds and use for obtaining n- phosphono-methylglycine
ES2014042A6 (es) Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo.
EP0316592A3 (fr) 3'-Fluoro-2',3'-didéoxyuridine, et ses application thérapeutique
EP0235904A3 (fr) Traitement de l'allergie avec la thymopentine

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed